Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer

BACKGROUND: This study investigated the predictive value of circulating microRNA-126 (cir-miRNA-126) in patients with metastatic colorectal cancer (mCRC) treated with first-line chemotherapy combined with bevacizumab. METHODS: The study included 68 patients. Blood samples (plasma) were collected bef...

Descripción completa

Detalles Bibliográficos
Autores principales: Hansen, T F, Carlsen, A L, Heegaard, N H H, Sørensen, F B, Jakobsen, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333496/
https://www.ncbi.nlm.nih.gov/pubmed/25584492
http://dx.doi.org/10.1038/bjc.2014.652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333496/
https://www.ncbi.nlm.nih.gov/pubmed/25584492
http://dx.doi.org/10.1038/bjc.2014.652

Ejemplares similares